Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
58,634.07 +773.70 (+1.34%) CMC Crypto 200
1,270.30 -0.44 (-0.03%)
A Jan 2025 65.000 put
| Previous close | 0.5000 |
| Open | 0.5000 |
| Bid | 0.0000 |
| Ask | 0.3000 |
| Strike | 65.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.5000 - 0.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 73 |
ZacksCognex Corporation (CGNX) Tops Q1 Earnings and Revenue Estimates
Cognex (CGNX) delivered earnings and revenue surprises of 37.50% and 6.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WirePadraig McDonnell Assumes Agilent CEO Role
SANTA CLARA, Calif., May 01, 2024--Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21. McDonnell is the fourth CEO in Agilent’s history and succeeds Mike McMullen, who will serve as an adviser until he retires Oct. 31.
Business WireAgilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
SANTA CLARA, Calif., May 01, 2024--Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains—from basic research to drug discovery and therapy development.
